WASHINGTON DC — The federal government spent the opening day of historic marijuana rescheduling hearings Monday making arguments that would have been almost unimaginable just a few years ago: cannabis has accepted medical use, carries lower abuse potential than drugs in Schedule I and II, and presents a lower overdose risk than opioids and alcohol.
Cannabis Industry Says It Has No Voice In Upcoming DEA Hearing That Could Affect Taxes, Research And Future Growth LANSING – Michigan's medical marijuana market has nearly vanished, generating just $322,350 in sales during May, according to the Michigan Cannabis Regulatory Agency. Yet a federal debate centered on marijuana's medical value could have sweeping consequences
LANSING – The regulator overseeing Michigan's $3.17 billion cannabis industry has been elected president of the nation's leading organization for marijuana and hemp regulators at a time when federal marijuana rescheduling and hemp regulation are reshaping the industry. Michigan Cannabis Regulatory Agency Executive Director Brian Hanna was elected president of the Cannabis Regulators Association (CANNRA)
Michigan still dominates cannabis sales and attracts thousands of out-of-state shoppers every week. But Ohio's higher prices, stronger profit margins and expanding adult-use market could position it to benefit more from upcoming federal cannabis reforms. ANN ARBOR - Michigan sells more cannabis than Ohio. Ohio makes more money. That simple reality may shape the future
WASHINGTON DC - A narrow federal window is opening that could reshape the future of the U.S. cannabis industry—and Michigan companies may have just weeks to decide whether to take part. The Drug Enforcement Administration has launched a new registration process for medical marijuana businesses, creating what some industry attorneys describe as a rare opportunity
ANN ARBOR - On April 23, the Department of Justice issued an order to reschedule medical marijuana in states from I to III. But that's about all we know for sure since the order didn't go into great detail on what that means. So Michigan Marijuana Today focuses on that order and what it could
ANN ARBOR - President Donald Trump’s decision to move marijuana out of the most restrictive federal drug category marks real progress in U.S. cannabis policy — progress that’s been a long time coming. By directing federal agencies to reschedule marijuana from Schedule I to Schedule III, the administration is finally acknowledging what science, voters, and
WASHINGTON DC - Marijuana business leaders are not optimistic that federal rescheduling will happen this year—though 97 percent said the reform and the resulting federal tax relief are “important” to their “long-term viability”—according to a new poll. Shield Compliance, which provides compliance management solutions for banks serving the legal cannabis industry, released the results of
WASHINGTON DC - President Donald Trump affirmed at a news conference Monday that his administration is “looking” at federally reclassifying cannabis and that it would “make a determination over the next few weeks.” He said that the subject is “complicated.” While he acknowledged hearing “great things” about cannabis’ medical utility, he also said that he’s heard “bad things having
ROYAL OAK - There’s been a lot of speculation that the Trump Administration could reschedule cannabis on a national level from Schedule 1 (No redeeming medical value) to Schedule 3 (substances with a moderate to low potential for physical or psychological dependence). If, and that’s a big If, Trump issues an executive order rescheduling cannabis,
